Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Researchers Awarded Almost £1 Million to Target High Blood Pressure

Published: Tuesday, August 21, 2012
Last Updated: Tuesday, August 21, 2012
Bookmark and Share
Study shows that reduced blood flow to the brain will trigger high blood pressure.

University of Bristol researchers have received funding of almost £1 million from the British Heart Foundation to provide novel therapeutic targets for the treatment of high blood pressure.

Affecting one in three people, the treatment of patients with high blood pressure has important clinical and financial implications for public health.

Although scientists know what factors can trigger high blood pressure many of the mechanisms that regulate the long-term control of blood pressure remain a mystery.

Scientists from the University’s School of Physiology and Pharmacology, who are leading the five-year study, believe that these underlying mechanisms are triggered by poor blood delivery to the brain which responds by pushing blood pressure up causing high blood pressure.

This process re-directs blood into the brain to restore adequate flow. In previous studies, involving patient and an animal model of human hypertension, the blood vessels supplying the brain with blood are narrow and resistant to flow.

They also fail to dilate when brain activity increases, which is a time when more blood flow is needed to deliver oxygen and nutrients. So, there appears a greater susceptibility for stroke in high blood pressure.

The study aims to provide new evidence that shows reduced blood flow to the brain will trigger high blood pressure and provide novel therapeutic targets for the treatment of high blood pressure.

Professor Julian Paton, the study’s lead scientist, said: “You have to consider the brain as the most selfish organ in the body; if it is not satiated with enough blood flow it is the most powerful organ in the body for ramping up the pressure.

“We are absolutely delighted to have been given this award from the British Heart Foundation as it directs much needed attention to the brain and provides the opportunity to come up with new ways to control blood pressure in patients that are devoid of the awful side effects of so many currently prescribed drugs.”

Professor Sergey Kasparov, co-investigator on the study added: “We will attempt to prevent the narrowing of brain arteries in high blood pressure so to improve blood flow, unearth the intra-cranial sensors that detect low brain blood flow that trigger high blood pressure and find out why brain vessels are reluctant to dilate when brain activity increases.”

Dr Hélène Wilson, Research Advisor at the British Heart Foundation (BHF), said: “We’re delighted to award almost £1 million to this Bristol team for their work on understanding the causes of high blood pressure, which can lead to greater risk of having a heart attack or stroke. This latest project is looking at a possible role for the brain in effective blood pressure control, and is part of a wide research programme that we hope will help lead us towards new treatments in the future."

The study, entitled ‘Brainstem hypoperfusion as a causative mechanism for neurogenic hypertension’ led by Professor Julian Paton at the University of Bristol, is funded by a British Heart Foundation grant of £980,415.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Findings Could Influence the Development of Therapies to Treat Dengue Disease
New research into the fight against Dengue may influence the development of anti-viral therapies that are effective against all four types of the virus.
Monday, August 05, 2013
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
A study to investigate Alzheimer’s disease led by scientists at the University of Bristol has been awarded funding by the Medical Research Council (MRC).
Tuesday, November 06, 2012
Scientific News
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos